SOLEUS CAPITAL MANAGEMENT, L.P. – Enanta Pharmaceuticals, Inc. Transaction History
SOLEUS CAPITAL MANAGEMENT, L.P. portfolio value:
$6.38M
portfolio value
SOLEUS CAPITAL MANAGEMENT, L.P. quarter portfolio value change:
+9.73%
quarter
Enanta Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +23.01% | 23.01K shares | 1.65M | $51.87 | 123.01K |
Q2 2022 | share | Decrease | -50.61% | -102.48K shares | -9.68M | $47.27 | 100K |
Q1 2022 | share | Decrease | -36.38% | -115.79K shares | -9.38M | $71.18 | 202.48K |
Q4 2021 | share | Increase | +74.49% | 135.87K shares | 13.43M | $74.57 | 318.27K |
Q3 2021 | share | Increase | 0.00% | 182.4K shares | 10.36M | $56.81 | 182.4K |
Q4 2020 | share | Decrease | -100.00% | -11.5K shares | -526K | $42.1 | 0 |
Q3 2020 | share | 0.00% | 0 shares | -51K | $45.78 | 11.5K | |
Q2 2020 | share | Increase | +8.49% | 900 shares | 32K | $50.21 | 11.5K |
Q1 2020 | share | Increase | 0.00% | 10.6K shares | 545K | $51.43 | 10.6K |